Biomarin Pharmaceutical Inc. (BMRN)

Index:

Nasdaq 100

$ 56.21
   
  • Change Today:
    $-0.97
  • 52 Week High: $72.83
  • 52 Week Low: $51.46
  • Currency: US Dollars
  • Shares Issued: 179.84m
  • Volume: 2,106,555
  • Market Cap: $10,109m
  • RiskGrade: 181
  • Beta: 0.02

Latest ShareCast News

BioMarin buys pharma peer Amicus for $4.8bn

By Benjamin Chiou

Date: Friday 19 Dec 2025

(Sharecast News) - Shares in BioMarin surged on Wall Street on Friday after the pharma group agreed to buy smaller peer Amicus Therapeutics for $4.8bn, expanding its position in the rare diseases market.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BMRN Market Data

Currency US Dollars
Share Price $ 56.21
Change Today $ -0.97
% Change -1.70 %
52 Week High $72.83
52 Week Low $51.46
Volume 2,106,555
Shares Issued 179.84m
Market Cap $10,109m
Beta 0.02
RiskGrade 181

What The Brokers Say

Strong Buy 10
Buy 8
Neutral 5
Sell 1
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 23-Jan-2026

Time Volume / Share Price
16:00 559,476 @ $56.21
15:59 100 @ $56.21
15:59 100 @ $56.21
15:59 100 @ $56.21
15:59 100 @ $56.20

Top of Page